Search cutoffs
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Current report (Form 8-K) · Jun 9, 2026 · Other material event · Item 5.07 · Financial statements
Arcutis Biotherapeutics, Inc.
7
Other material event
Jun 9, 2026
| Form type | Current report (Form 8-K) |
| Event summary | Other material event · Item 5.07 · Financial statements |
| Primary topic | Other material event |
| About this form | Public companies file this within four business days when something important happens that investors should know about, before the next quarterly report. |
| Why this was filed | Arcutis Biotherapeutics, Inc. filed this to release information to investors under Regulation FD, usually a press release, conference presentation, or other event the company considers important. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230. 425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240. |
| Labor angle | Watch for Item 2.05 (restructuring or severance), Item 5.02 (leadership changes), and Item 1.01 (major contracts that can precede workforce shifts). |
| Period of report | Jun 5, 2026 |
| Accession number | 0001628280-26-041883 |
| Reported items | Item 5.07, Other events the company considers material, Financial statements and exhibits See Analysis tab for workforce implications |
